Everdime Technologies, Inc.
RGST · OTC
3/31/2024 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 55.9% | – | 100% | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | $0 | -$0 | $0 | -$0 |
| % Margin | 17.1% | – | 2.9% | – |
| Other Income/Exp. Net | -$0 | $0 | -$0 | $0 |
| Pre-Tax Income | $0 | -$0 | $0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | -$0 | $0 | -$0 |
| % Margin | 16% | – | 2.6% | – |
| EPS | 0 | -0.001 | 0 | -0.003 |
| % Growth | 160% | -3,253.3% | 100.6% | – |
| EPS Diluted | 0 | -0.001 | 0 | -0.003 |
| Weighted Avg Shares Out | 156 | 156 | 156 | 155 |
| Weighted Avg Shares Out Dil | 156 | 156 | 156 | 155 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | -$0 | $0 | $0 |
| EBITDA | $0 | -$0 | $0 | -$0 |
| % Margin | 22.7% | – | 2.9% | – |